|
Previous: BOSTON LIFE SCIENCES INC /DE, 8-K, EX-10.1, 2000-06-09 |
Next: BOSTON LIFE SCIENCES INC /DE, 8-K, EX-10.3, 2000-06-09 |
<PAGE> Exhibit 10.2 Schedule 4.3 I. Authorized Capital A. Common Stock 30 million B. Preferred stock 1 million, of which approximately 15,000 have been designated as Series A and of which 475,000 have been designated as Series C Convertible Preferred Stock II. Outstanding Capital Equivalent Shares of Common Stock --------------------------------- A. Common Stock approximately 19,000,000 B. Stock Options approximately 2,100,000 C. Warrants approximately 4,600,000
|